樂普醫療(300003.SZ):監事會主席王興林逝世
格隆匯5月9日丨樂普醫療(300003.SZ)公佈,公司沉痛公吿,公司第六屆監事會主席王興林先生因病醫治無效於近日不幸逝世。公司董事、監事、高級管理人員及全體員工對王興林先生的不幸逝世表示沉痛哀悼和深切緬懷,並向其親屬致以深切的慰問!
王興林先生在擔任公司監事會主席期間,恪盡職守、勤勉盡責,忠實地履行了作為監事會主席應盡的職責和義務,在保障公司監事會合規決策、維護公司及股東的整體利益等方面盡職盡責,為公司規範運作和高質量發展發揮了積極作用。公司對王興林先生為公司發展所做的努力和貢獻表示衷心感謝!
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.